Trials / Conditions / Lou Gehrig's Disease
Lou Gehrig's Disease
8 registered clinical trials studyying Lou Gehrig's Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Digital Speech Markers for Monitoring ALS in Spanish Speakers NCT07341334 | Nova Southeastern University | — |
| Completed | Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS NCT03520517 | Biohaven Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Trial of Tocilizumab in ALS Subjects NCT02469896 | Barrow Neurological Institute | Phase 2 |
| Completed | Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis NCT00956488 | Wake Forest University Health Sciences | Phase 1 / Phase 2 |
| Completed | Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) NCT00677768 | Massachusetts General Hospital | — |
| Completed | Clinical Trial of High Dose CoQ10 in ALS NCT00243932 | Columbia University | Phase 2 |
| Completed | Genetics of Familial and Sporadic ALS NCT00821132 | Northwestern University | — |
| No Longer Available | Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) NCT03537807 | Biohaven Pharmaceuticals, Inc. | — |